Products

BoneMetrics (US)
Gleamer
Clinical Decision Support & Reference
BoneMetrics automates orthopedic measurements from trauma X-rays, reducing variability and saving time with AI-calculated angles and distances for spinal deformities like scoliosis.
ChestView US
Gleamer
Radiology & Imaging AI
ChestView US by Gleamer SAS is an FDA-cleared AI-powered Computer-Assisted Detection (CADe) software for chest X-rays, assisting radiologists and emergency medicine physicians in detecting multiple pathologies and reducing reading times.
BoneView
Gleamer
Radiology & Imaging AI
Gleamer BoneView is an FDA-cleared AI solution for X-ray fracture detection, enhancing diagnostic accuracy and workflow efficiency for radiologists and clinicians in trauma and musculoskeletal care.

See all 3 products →

About Gleamer

Gleamer is a French medtech company that specializes in developing AI-powered software solutions to enhance diagnostic capabilities in radiology. Founded in 2017, the company aims to address the increasing demand for medical imaging and the challenges faced by radiologists due to an aging population, rising chronic diseases, and limited access to healthcare. [1, 4]

For physicians, Gleamer’s AI solutions, integrated into their ‘Gleamer Copilot’ platform, are designed to support and improve the diagnostic process across various imaging modalities, including X-ray, mammography, CT, and MRI. [1, 4, 10] Their products, such as BoneView for trauma X-rays, ChestView for chest X-rays, BoneMetrics for musculoskeletal measurements, and BreastView for mammography, assist in automatically detecting potential abnormalities, providing preliminary data for diagnosis, and generating structured reports. [1, 4, 5, 6, 12, 17] This technology aims to improve diagnostic accuracy, reduce reading times, optimize workflow efficiency, and ultimately contribute to better patient care by offering a transparent concurrent reading aid. [1, 5, 17, 25]

Gleamer’s solutions are FDA-cleared and CE-marked, and they are deployed in over 3,500 clinical sites across more than 50 countries, processing over 60 million exams annually. [1, 6] The company’s mission is to empower healthcare professionals with advanced AI tools, ensuring consistent diagnostic quality and making high-quality care accessible, especially in regions with a shortage of radiologists. [5, 8, 11]

Focus Areas

radiology AI medical imaging artificial intelligence diagnostic support X-ray CT MRI mammography bone trauma detection chest pathology detection musculoskeletal measurements bone age assessment breast cancer detection neurological conditions lumbar spine MRI interpretation

Business Intelligence

Technologycloud-first, AI-powered health informatics, deep learning algorithms

What Physicians Need to Know

Specialization
Gleamer specializes in AI-powered solutions for radiology, focusing on medical imaging analysis across various modalities including X-ray, CT, MRI, and mammography.
Key Products
Their product suite includes BoneView (for bone trauma detection on X-rays), ChestView (for chest X-ray analysis, detecting critical findings like pneumothorax and early signs of cancer), BoneMetrics (for automating musculoskeletal measurements), and BoneAge (for automated bone age assessment).
Diagnostic Accuracy
Gleamer's AI-driven algorithms enhance diagnostic accuracy by identifying anomalies in medical images that might be difficult for the human eye to spot.
Efficiency and Workflow
The solutions are designed to increase efficiency in radiology workflows, reduce reporting turnaround times, and automate repetitive tasks, allowing radiologists to focus on higher-value clinical decisions.
Clinical Validation & Certifications
Gleamer's technology is clinically proven, FDA & CE certified, and backed by rigorous peer-reviewed studies, with applications analyzing over 40 million patient exams annually.
Global Reach
Gleamer's solutions are deployed in over 2,500 institutions across 45 countries, with a strong presence in Europe and the United States.
Technology Stack
Gleamer leverages a cloud-native architecture, specifically partnering with Google Cloud since 2021 for scalability, performance, security, and compliance (HDS certified, equivalent to HIPAA). They integrate Google Cloud's Vertex AI models, including Med-PaLM and Gemini, for advanced medical data analysis and automated report drafting.
Physician Tip

For physicians, Gleamer acts as a 'safety net' to catch subtle findings and rare pathologies that the human eye might miss, improving sensitivity and accuracy across various imaging modalities. It significantly reduces the amount of missed fractures (by 30% with BoneView) and can increase sensitivity on chest X-rays by up to 50% with ChestView. The automated reporting and seamless workflow integration save valuable time, with products like BoneAge offering a 72% average time gain per exam and BoneMetrics reducing annotation time by 93%. This allows radiologists to enhance patient care, especially in emergency settings or during nighttime shifts where radiologist shortages may exist.

Gleamer's solutions are designed for seamless integration with existing medical imaging systems, including PACS/RIS, allowing healthcare professionals to use them alongside other tools. The Gleamer Copilot acts as a single gateway to orchestrate all solutions and modalities, supporting advanced workflows like worklist prioritization and shadow mode. It also offers longitudinal follow-up by connecting prior and present exams and ensures data privacy through patient pseudonymization, adhering to HIPAA and GDPR compliance.

Products by Gleamer

3 products in the directory

BoneMetrics (US)
Gleamer
Clinical Decision Support & Reference
BoneMetrics automates orthopedic measurements from trauma X-rays, reducing variability and saving time with AI-calculated angles and distances for spinal deformities like scoliosis.
ChestView US
Gleamer
Radiology & Imaging AI
ChestView US by Gleamer SAS is an FDA-cleared AI-powered Computer-Assisted Detection (CADe) software for chest X-rays, assisting radiologists and emergency medicine physicians in detecting multiple pathologies and reducing reading times.
BoneView
Gleamer
Radiology & Imaging AI
Gleamer BoneView is an FDA-cleared AI solution for X-ray fracture detection, enhancing diagnostic accuracy and workflow efficiency for radiologists and clinicians in trauma and musculoskeletal care.

What the Web Says

Gleamer is a French company established in 2016 that develops AI-driven solutions for medical imaging, primarily assisting radiologists and healthcare professionals in analyzing medical images and diagnosing conditions. Their flagship product, BoneView, is an AI-driven X-ray interpretation tool that helps detect fractures, effusions, dislocations, and focal bone lesions. While the company is recognized for its cutting-edge AI algorithms and intuitive interface, there is limited public information available regarding comprehensive product or employer reviews on major platforms like G2, Glassdoor, Capterra, or Reddit specifically for "Gleamer" as a medical imaging AI company.

Overall: Mixed

Strengths

  • AI-driven algorithms enhance image quality and provide accurate interpretations.
  • Helps identify anomalies in medical images that may be difficult for the human eye to spot.
  • Supports various imaging modalities including X-rays, MRIs, and CT scans.
  • Intuitive interface allows for easy navigation, annotation, and secure sharing of results.
  • Integrates seamlessly with existing medical imaging systems.
  • Facilitates generation of detailed diagnostic reports, improving communication.

Limitations

  • Limited public reviews available on major platforms (G2, Glassdoor, Capterra, Reddit) specifically for Gleamer as a medical imaging AI company.
  • One Reddit comment mentions Gleamer AI picking up "ghost fractures" on kids' X-rays, leading to unnecessary reassurance for ED doctors.
  • Some general Reddit discussions about AI in radiology suggest other tools might have higher sensitivity and AUC for fracture detection.
  • Lack of detailed information on company culture, salaries, or work-life balance from employee reviews.
  • Pricing information is not readily available and requires a custom quote.
  • Documentation and tutorials for the Gleam programming language (a separate entity) are noted as lacking.

Based on reviews from: ITQlick, SoftwareWorld, Elion Health, Software Advice, Reddit

Last updated: 2026-10-20

Videos

News, demos, and interviews about Gleamer.

Loading videos...

Videos load interactively. If none appear, search YouTube for Gleamer →

View all on YouTube

Press & Coverage

MedCity News
RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
RadNet acquired Gleamer for $269 million, integrating it into its DeepHealth subsidiary to become the largest provider of radiology clinical AI solutions globally.
2026-03
Radiology Business
Radiology AI firm Gleamer expands into MRI with 2 acquisitions
Gleamer expanded its AI offerings into MRI by acquiring French firms Pixyl and Caerus Medical, aiming to address radiologist shortages and the growing popularity of whole-body MRI.
2025-03
PR Newswire
Gleamer Receives FDA Clearance for ChestView
Gleamer's ChestView, an AI solution for chest X-ray interpretation, received FDA clearance for simultaneously detecting multiple findings, enhancing diagnostic sensitivity.
2025-03
AuntMinnie
Gleamer nabs $29.5M in funding
Gleamer raised $29.5 million in a Series B funding round, bringing its total funding to $39.4 million, to expand its product portfolio and grow its teams in Europe and the U.S.
2023-06
Diagnostic Imaging
Gleamer's BoneView Gains FDA Clearance for AI-Powered Pediatric Fracture Detection
Gleamer's BoneView AI software received FDA 510(k) clearance for pediatric fracture detection, making it the first AI fracture detection modality cleared for use in patients over two years of age.
2023-03
PR Newswire
GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and Localize Fractures
Gleamer announced FDA clearance for its BoneView AI software to aid in diagnosing fractures and traumatic injuries on X-rays for U.S. healthcare specialists.
2022-03
HIT Consultant
RadNet Makes $269M Bet on AI with DeepHealth's Acquisition of France's Gleamer
RadNet's acquisition of Gleamer for $269 million is a strategic move to bolster its AI imaging portfolio and integrate Gleamer's automated reporting and triage capabilities across its network.
2026-03
PSL
From the PSL ecosystem to an international group: start-up Gleamer acquired for €230 million
Gleamer, a French medtech company specializing in AI for radiological diagnosis, was acquired by RadNet for €230 million, highlighting the global appeal of French tech innovation.
2026-03

Frequently Asked Questions

Gleamer offers a suite of AI solutions, integrated into their Gleamer Copilot®, designed to assist radiologists in analyzing medical images. Their product portfolio includes BoneView for fracture detection on X-rays, ChestView for chest X-ray analysis (detecting pneumothorax, nodules, etc.), BoneMetrics for musculoskeletal measurements, and BoneAge for automated bone age assessment. They also have solutions for mammography (BreastView), CT scans (LungCT, BoneCT), and MRI (Pixyl.Neuro.MS, Pixyl.Neuro.BV for neurological MRI, and LumbarMR for lumbar spine MRI), aiming to cover all imaging modalities.
Gleamer is committed to protecting user privacy and ensuring compliance with regulations such as the European Regulation 2016/679 on data protection and the amended French 'Informatique et Libertés' law. Their solutions implement measures like data segregation and pseudonymization techniques to limit personal information received for processing medical images. Their partnership with Google Cloud also highlights their use of Google Cloud's HDS (Health Data Host) certification, which is equivalent to US HIPAA standards, guaranteeing optimal security and compliance for sensitive medical data.
Gleamer offers a tiered pricing structure, but specific details are not publicly available. Estimates suggest a monthly license cost starting around $500 per user, scaling up for more users and modules. Potential hidden costs might include additional fees for exceeding usage limits, advanced training, or specialized customization. Implementation, customization, training, and data migration costs can also vary based on deployment complexity.
While specific details on support and maintenance are not extensively detailed in public information, Gleamer's solutions are designed for seamless integration into existing radiology workflows, including PACS and EMR systems. Their AI Copilot offers a unified experience across solutions to help radiologists master products quickly. The company also emphasizes its commitment to improving quality of care through trusted clinical AI seamlessly integrated into hospital workflows.
Gleamer has established significant partnerships to expand its reach and enhance its offerings. Notably, they have a strategic partnership with Google Cloud for robust and scalable technological infrastructure. They also partner with companies like Aidoc, Fujifilm, Ferrum Health, and Blackford Analysis for distribution and integration of their solutions. Additionally, Gleamer has formed strategic alliances with organizations like France Imageries Territoires and Aamal Medical to deploy their AI solutions across broader networks and regions.
Gleamer, founded in 2017, was acquired by the US giant RadNet, Inc. in March 2026 for up to €230 million (approximately $270 million). This acquisition by RadNet's DeepHealth subsidiary positions DeepHealth as a global leader in radiology clinical AI solutions. Gleamer had demonstrated strong growth with a compound annual recurring revenue growth exceeding 90% from 2022 to 2025, and was expected to reach approximately $30 million ARR in 2026.

Investors

Who's funded Gleamer.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.